Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme eye drops in Sjogren's and Non-Sjogren dry eye disease
NCT02193490Phase 2Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Jul 2014
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
A Phase 2 trial of dornase alfa in dry eye disease (DED), sponsored by University of Illinois Chicago. Started Jul 2014; status: terminated.
02
Drugs
dornase alfa
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02193490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193490.